This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Baird analyst Catherine Schulte downgraded the rating for Qiagen N.V. QGEN from Outperform to Neutral and lowered the price target from $52 to $42. Qiagen shares closed at $40.01 on Tuesday. See how other analysts view this stock.
Baird analyst Catherine Schulte downgraded Bio-Techne Corporation TECH from Outperform to Neutral and lowered the price target from $88 to $68. Bio-Techne shares closed at $65.29 on Tuesday. See how other analysts view this stock.
Morgan Stanley analyst Keith Weiss downgraded Workday, Inc. WDAY from Overweight to Equal-Weight and lowered the price target from $330 to $275. Workday shares closed at $265.72 on Tuesday. See how other analysts view this stock.
B. Riley Securities analyst Kyle Bauser downgraded the rating for Tactile Systems Technology, Inc. TCMD from Buy to Neutral and slashed the price target from $23 to $18. Tactile Systems shares closed at $17.86 on Tuesday. See how other analysts view this stock.
Cantor Fitzgerald analyst Kristen Kluska downgraded Supernus Pharmaceuticals, Inc. SUPN from Overweight to Neutral and lowered the price target from $57 to $36. Supernus Pharmaceuticals shares closed at $39.75 on Tuesday. See how other analysts view this stock.